References
-
Ahn J, Lee H, Kim S & Ha T (2007). Resveratrol inhibits TNF-
${\alpha}$ -induced changes of adipokines in 3T3-L1 adipocytes. Biochem Biophys Res Commun 364:972-977 https://doi.org/10.1016/j.bbrc.2007.10.109 - Aviram M & Fuhrman B (2002). Wine flavonoids protect against LDLoxidation and atherosclerosis. Ann NY Acad Sci 957:146-161 https://doi.org/10.1111/j.1749-6632.2002.tb02913.x
- Baur JA & Sinclair DA (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506 https://doi.org/10.1038/nrd2060
- Belleville J (2002). The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition 18:173-177 https://doi.org/10.1016/S0899-9007(01)00721-3
- Berk BC, Abe JI, Min W, Surapisitchat H & Yan C (2001). Endothelial atheroprotective and anti-inflammatory mechanisms. Ann N Y Acad Dci 947:93-111
- Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M & Bertelli A (1995). Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 17:1-3
- Bradamante S, Barenghi L & Villa A (2004). Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22:169-188 https://doi.org/10.1111/j.1527-3466.2004.tb00139.x
- Choi YJ, Jeong YJ, Lee YJ, Kwon HM & Kang YH (2005). (-) Epigallocatechin gallate and quercetin enhance survival signaling in response to oxidant-induced human endothelial apoptosis. J Nutr 135:707-713
- Chow SE, Hshu YC, Wang JS & Chen JK (2007). Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages. J Appl Physiol 102:1520-1527 https://doi.org/10.1152/japplphysiol.00881.2006
- Cullen JP, Morrow D, Jin Y, von Offenberg Sweeney N, Sitzmann JV, Cahill PA & Redmond EM (2007). Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes. Atherosclerosis 195:e125-e133 https://doi.org/10.1016/j.atherosclerosis.2007.03.039
- de Lange DW, Verhoef S, Gorter G, Kraaijenhagen RJ, van de Wiel A & Akkerman JW. (2007) Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox. Alcohol Clin Exp Res 31:1308-1314 https://doi.org/10.1111/j.1530-0277.2007.00439.x
-
Fukuhara K, Nagakawa M, Nakanishi I, Ohkubo K, Imai K, Urano S, Fukuzumi S, Ozawa T, Ikota N, Mochizuki M, Miyata N & Okuda H (2006). Structural basis for DNA-cleaving activity of resveratrol in the presence of
$Cu^{2+}$ . Bioorg Med Chem 14: 1437-1443 https://doi.org/10.1016/j.bmc.2005.09.070 - Gagliano N, Moscheni C, Torri C, Magnani I, Bertelli AA & Gioia M (2005). Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells. Biomed Pharmacother 59:359-364 https://doi.org/10.1016/j.biopha.2005.06.001
- Galis ZS, Sukhova GK, Lark MW & Libby P (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503 https://doi.org/10.1172/JCI117619
- Hao HD & He LR (2004). Mechanisms of cardiovascular protection by resveratrol. J Med Food 7:290-298 https://doi.org/10.1089/jmf.2004.7.290
- Hu J, Huang Y, Xiong M, Luo S, Chen Y & Li Y (2006). The effects of natural flavonoids on lipoxygenase-mediated oxidation of compounds with a benzene ring structure-a new possible mechanism of flavonoid anti-chemical carcinogenesis and other toxicities. Int J Toxicol 25:295-301 https://doi.org/10.1080/10915810600746122
- Katiyar SK (2006). Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins. Endocr Metab Immune Disord Drug Targets 6:17-24 https://doi.org/10.2174/187153006776056648
- Krasinski K, Spyridopoulos I, Kearney M & Losordo DW (2000). In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. Circulation 104:1754-1756 https://doi.org/10.1161/hc4001.098046
- Middleton E. Jr, Kandaswami C & Theoharides TC (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation heart disease and cancer. Pharmacol Rev 52:673-751
- Nagaoka I & Hirota S (2000). Increased expression of matrix metalloproteinase-9 in neutrophils in glycogen-induced peritoneal inflammation of guinea pigs. Inflamm Res 49:55-62
- Nakashima Y, Raines EW, Plump AS, Breslow JL & Ross R (1998). Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the Apo-E-deficient mouse. Arterioscler Thromb Vasc Biol 18:842-851 https://doi.org/10.1161/01.ATV.18.5.842
- Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K & van Leeuwen PA (2001). Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425 https://doi.org/10.1093/ajcn/74.4.418
- Pober JS & Cotran RS (1990). The role of endothelial cells in inflammation. Transplantation 50:537-533 https://doi.org/10.1097/00007890-199010000-00001
- Ross R (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809 https://doi.org/10.1038/362801a0
- Saarialho-Kere UK, Welgus HG & Parks WC (1993). Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J Biol Chem 268:7354-7361
- Schonbeck U, Mach F & Libby P (2000). CD154 (CD40 ligand). Int J Biochem Cell Biol 32:687-693 https://doi.org/10.1016/S1357-2725(00)00016-9
- Shankar S, Singh G & Srivastava RK (2007). Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 12:4839-4854 https://doi.org/10.2741/2432
- Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M & Schini-Kerth VB (2004). Vascular protection by dietary polyphenols. Eur J Pharmacol 500:299-313 https://doi.org/10.1016/j.ejphar.2004.07.034
- Teixeira S, Siquet C, Alves C, Boal I, Marques MP, Borges F, Lima JL & Reis S (2005). Structure-property studies on the antioxidant activity of flavonoids present in diet. Free Radic Biol Med 39:1099-108 https://doi.org/10.1016/j.freeradbiomed.2005.05.028
- Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS, Lee YH, Park JW & Kwon TK (2004). Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23:1845-1853 https://doi.org/10.1038/sj.onc.1207307
- Wung BS, Hsu MC, Wu CC & Hsieh CW (2005). Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci 78:389-397 https://doi.org/10.1016/j.lfs.2005.04.052
- Zhu Z, Klironomos G, Vachereau A, Neirinck L & Goodman DW (1999). Determination of trans-resveratrol in human plasma by high-performance liquid chromatography. J Chromatogr B 724: 389-392 https://doi.org/10.1016/S0378-4347(98)00586-6